Crossbow Therapeutics
About:
Crossbow Therapeutics is a biotech company developing a new type of cancer treatment.
Website: https://www.crossbowtx.com
Top Investors: Eli Lilly, Polaris Partners, Mirae Asset Capital, Biotechnology Value Fund, Mirae Asset Venture Investment
Description:
Crossbow Therapeutics is a biotech company developing a new type of cancer treatment. They engineer antibodies to mimic T-cells, a natural part of the immune system, with the goal of improving the lives of cancer patients.
Total Funding Amount:
$80M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Cambridge, Massachusetts, United States
Founded Date:
2021-01-01
Founders:
Geraldine Paulus
Number of Employees:
11-50
Last Funding Date:
2023-07-11
IPO Status:
Private
Industries:
© 2025 bioDAO.ai